Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin pharmacogenetic study in chronic low back pain
ACTRN12616001649404Phase 4Withdrawn
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pregabalin in chronic low back pain (CLBP), lumbosacral radiculopathy and Neuralgia, sponsored by Aristotle University of Thessaloniki. Primary endpoints: Correlation of total pregabalin requirements with gene polymorphisms and Correlation of gene polymorphisms with pain response. Planned start Dec 2016; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
chronic low back pain (CLBP)lumbosacral radiculopathyNeuralgia
Beyond the preview
Go deeper on ACTRN12616001649404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001649404.